Cargando…

Reduction of radiation pneumonitis by V20-constraints in breast cancer

INTRODUCTION: Adjuvant local-regional radiotherapy (LRRT) is routinely recommended for breast cancer patients. It is well known being related to pulmonary side-effects. We studied post-RT radiological changes on X-ray and CT, and correlated the findings with Quality of Life (QoL), common dosimetric...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldman, Ulla Blom, Wennberg, Berit, Svane, Gunilla, Bylund, Håkan, Lind, Pehr
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2987943/
https://www.ncbi.nlm.nih.gov/pubmed/21034456
http://dx.doi.org/10.1186/1748-717X-5-99
_version_ 1782192191409487872
author Goldman, Ulla Blom
Wennberg, Berit
Svane, Gunilla
Bylund, Håkan
Lind, Pehr
author_facet Goldman, Ulla Blom
Wennberg, Berit
Svane, Gunilla
Bylund, Håkan
Lind, Pehr
author_sort Goldman, Ulla Blom
collection PubMed
description INTRODUCTION: Adjuvant local-regional radiotherapy (LRRT) is routinely recommended for breast cancer patients. It is well known being related to pulmonary side-effects. We studied post-RT radiological changes on X-ray and CT, and correlated the findings with Quality of Life (QoL), common dosimetric factors and co-variates. The results were compared with a previously reported cohort of 137 irradiated women. METHODS: 88 women underwent chest X-ray and CT pre-and 4-5 months after 3-D planned LRRT, minimizing the dose to the ipsilateral lung to V(20 )< 30%. The lung field was divided into 3 regions and the development of post-RT density changes were graded (0-3). Patients with radiological changes were compared with non-responders. Clinical symptoms were registered and data on patient and treatment related co-variates were gathered prospectively. The ipsilateral lung dosimetric factors V(13), V(20), V(30 )and mean dose were calculated and QoL was assessed before and 4 months after RT. RESULTS: The use of dose-volume constraints significally reduced moderate-severe radiological changes on chest X-ray compared with our earlier study (Chi square trend test: p < 0.001). Symptomatic pneumonitis was also rare in the present study. No agreement was found between CT and chest X-ray as diagnostic tools for post-RT pneumonitis. V(13 )correlated independently with radiological changes on CT (logistic regression: p = 0.04; ROC area: 0.7). The Co-variates smoking habits, age, chemotherapy, endocrine or trastuzumab therapy did not influence the outcome on multivariate analysis. QoL changes in physical function, i.e. fatigue, dyspnoea were not detected but there was a trend for a worse recovery after chemotherapy in patients with high V(13 )(Spearman Rank Correlation: p < 0.05). CONCLUSIONS: The use of dose-volume constraints significantly reduced post-RT radiological changes on chest X-ray in LRRT for BC. The lung changes on CT were also generally limited when we used this strategy and was not always picked up on chest X-ray. Variation in V(13 )alone was correlated with occurrence of lung changes on CT.
format Text
id pubmed-2987943
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29879432010-11-19 Reduction of radiation pneumonitis by V20-constraints in breast cancer Goldman, Ulla Blom Wennberg, Berit Svane, Gunilla Bylund, Håkan Lind, Pehr Radiat Oncol Research INTRODUCTION: Adjuvant local-regional radiotherapy (LRRT) is routinely recommended for breast cancer patients. It is well known being related to pulmonary side-effects. We studied post-RT radiological changes on X-ray and CT, and correlated the findings with Quality of Life (QoL), common dosimetric factors and co-variates. The results were compared with a previously reported cohort of 137 irradiated women. METHODS: 88 women underwent chest X-ray and CT pre-and 4-5 months after 3-D planned LRRT, minimizing the dose to the ipsilateral lung to V(20 )< 30%. The lung field was divided into 3 regions and the development of post-RT density changes were graded (0-3). Patients with radiological changes were compared with non-responders. Clinical symptoms were registered and data on patient and treatment related co-variates were gathered prospectively. The ipsilateral lung dosimetric factors V(13), V(20), V(30 )and mean dose were calculated and QoL was assessed before and 4 months after RT. RESULTS: The use of dose-volume constraints significally reduced moderate-severe radiological changes on chest X-ray compared with our earlier study (Chi square trend test: p < 0.001). Symptomatic pneumonitis was also rare in the present study. No agreement was found between CT and chest X-ray as diagnostic tools for post-RT pneumonitis. V(13 )correlated independently with radiological changes on CT (logistic regression: p = 0.04; ROC area: 0.7). The Co-variates smoking habits, age, chemotherapy, endocrine or trastuzumab therapy did not influence the outcome on multivariate analysis. QoL changes in physical function, i.e. fatigue, dyspnoea were not detected but there was a trend for a worse recovery after chemotherapy in patients with high V(13 )(Spearman Rank Correlation: p < 0.05). CONCLUSIONS: The use of dose-volume constraints significantly reduced post-RT radiological changes on chest X-ray in LRRT for BC. The lung changes on CT were also generally limited when we used this strategy and was not always picked up on chest X-ray. Variation in V(13 )alone was correlated with occurrence of lung changes on CT. BioMed Central 2010-10-29 /pmc/articles/PMC2987943/ /pubmed/21034456 http://dx.doi.org/10.1186/1748-717X-5-99 Text en Copyright ©2010 Goldman et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Goldman, Ulla Blom
Wennberg, Berit
Svane, Gunilla
Bylund, Håkan
Lind, Pehr
Reduction of radiation pneumonitis by V20-constraints in breast cancer
title Reduction of radiation pneumonitis by V20-constraints in breast cancer
title_full Reduction of radiation pneumonitis by V20-constraints in breast cancer
title_fullStr Reduction of radiation pneumonitis by V20-constraints in breast cancer
title_full_unstemmed Reduction of radiation pneumonitis by V20-constraints in breast cancer
title_short Reduction of radiation pneumonitis by V20-constraints in breast cancer
title_sort reduction of radiation pneumonitis by v20-constraints in breast cancer
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2987943/
https://www.ncbi.nlm.nih.gov/pubmed/21034456
http://dx.doi.org/10.1186/1748-717X-5-99
work_keys_str_mv AT goldmanullablom reductionofradiationpneumonitisbyv20constraintsinbreastcancer
AT wennbergberit reductionofradiationpneumonitisbyv20constraintsinbreastcancer
AT svanegunilla reductionofradiationpneumonitisbyv20constraintsinbreastcancer
AT bylundhakan reductionofradiationpneumonitisbyv20constraintsinbreastcancer
AT lindpehr reductionofradiationpneumonitisbyv20constraintsinbreastcancer